Clinical Trials Directory

Trials / Completed

CompletedNCT05899478

Suture-mediated Closure System Following Endovascular Peripheral Arterial Procedures

Prospective, Multi-center, Randomized Controlled Study to Evaluate the Effectiveness and Safety of Suture-mediated Closure System Following Endovascular Peripheral Arterial Procedures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
135 (actual)
Sponsor
Suzhou Hengruihongyuan Medical Technology Co. LTD · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effectiveness and safety of the suture-mediated closure system produced by Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. following endovascular peripheral arterial procedures.

Detailed description

Prospective, multi-center, randomized Comparative study using the Suture-mediated Closure System produced by Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.as an investigational device and the Perclose® ProGlide Suture-Mediated Closure System as a comparator. After going through the confirmation of inclusion/exclusion criteria with signed subjects, they will have a procedure either of the two devices. The subjects should follow designated physician's instructions accurately during the clinical trial period. There are about 4 times evaluations Including screening.

Conditions

Interventions

TypeNameDescription
DEVICETyknot® Suture-Mediated Closure SystemArterial closure to ensure hemostasis at femoral artery puncture points
DEVICEPerclose® ProGlide Suture-Mediated Closure SystemArterial closure to ensure hemostasis at femoral artery puncture points

Timeline

Start date
2023-06-01
Primary completion
2024-01-01
Completion
2024-04-01
First posted
2023-06-12
Last updated
2025-06-25

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05899478. Inclusion in this directory is not an endorsement.